Petersdorf Effie W
University of Washington, Fred Hutchinson Cancer Research Center, D4-100, Seattle, WA 98109, USA.
Curr Opin Immunol. 2006 Oct;18(5):559-64. doi: 10.1016/j.coi.2006.07.003. Epub 2006 Jul 25.
The MHC on human chromosome 6p21 encodes the HLA genes that govern histocompatibility in transplantation. Selection of potential unrelated volunteer donors for hematopoietic cell transplantation has required an understanding of the role of HLA gene products in mediating graft-versus-host and host-versus-graft alloreactions that give rise to the 'transplantation barrier'. Recent advances in the immunogenomics of the MHC in unrelated hematopoietic cell transplantation have been made through systemic examination of the alleles and antigens of large populations of racially and ethnically diverse transplant donors and recipients. The importance of non-HLA MHC-resident genetic variation in clinical outcome is increasingly being recognized. These data show that clinical outcome following transplantation is shaped by the combined effects of many genes within the MHC and their sequence polymorphisms.
人类6号染色体p21上的主要组织相容性复合体(MHC)编码了在移植中决定组织相容性的人类白细胞抗原(HLA)基因。为造血细胞移植选择潜在的非亲属志愿供者需要了解HLA基因产物在介导移植物抗宿主和宿主抗移植物同种异体反应中所起的作用,这些反应构成了“移植障碍”。通过对种族和民族多样化的大量移植供者和受者群体的等位基因和抗原进行系统研究,在无关造血细胞移植中MHC免疫基因组学方面取得了最新进展。非HLA MHC驻留基因变异对临床结果的重要性日益得到认可。这些数据表明,移植后的临床结果是由MHC内许多基因及其序列多态性的综合作用所决定的。